Cargando…

Supraglottitis as the sole manifestation of COVID-19 in a patient who received two doses of mRNA vaccine

Detalles Bibliográficos
Autores principales:	Chang, Kai-Ming, Epstein, Marcia E., Kennedy, William A., Niknam, Negin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046100/ https://www.ncbi.nlm.nih.gov/pubmed/35545499 http://dx.doi.org/10.1016/j.jmii.2022.04.010

Ejemplares similares

LATE ONSET NODULAR PRURIGO – THE SOLE AND INITIAL MANIFESTATION OF OCCULT HODGKIN'S DISEASE
por: Mehta, Vandana, et al.
Publicado: (2009)

A third dose of COVID‐19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant
por: Toya, Takashi, et al.
Publicado: (2022)

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
por: Hall, Victoria G., et al.
Publicado: (2021)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
por: Regev-Yochay, Gili, et al.
Publicado: (2022)

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
por: Kamar, Nassim, et al.
Publicado: (2021)

How important is the second dose of the COVID-19 mRNA vaccine?
por: Liu, Anne Y.
Publicado: (2021)

Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine
por: Bradley, Todd, et al.
Publicado: (2021)

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
por: Kuhlmann, Constanze, et al.
Publicado: (2022)

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

Pedal Poppers: Soles to Hold
por: Nikam, Balkrishna, et al.
Publicado: (2016)

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
por: Doria-Rose, Nicole, et al.
Publicado: (2021)

Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine
por: Finsterer, Josef, et al.
Publicado: (2021)

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
por: Wu, Kai, et al.
Publicado: (2021)

The structure of the SOLE element of oskar mRNA
por: Simon, Bernd, et al.
Publicado: (2015)

SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis
por: Liao, Shu-Yi, et al.
Publicado: (2022)

Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021)

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
por: Krammer, Florian, et al.
Publicado: (2021)

Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
por: Yoon, Sarang K., et al.
Publicado: (2022)

Intriguing Bumps Over Palms and Soles
por: Doshi, Bhavana R, et al.
Publicado: (2019)

No psychological vaccination: Vaccine hesitancy is associated with negative psychiatric outcomes among Israelis who received COVID-19 vaccination
por: Palgi, Yuval, et al.
Publicado: (2021)

Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2023)

Psoriatic arthritis flare-up after a second dose of BNT162b2 COVID-19 mRNA vaccine
por: Watabe, Daisuke, et al.
Publicado: (2022)

Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion
por: Zauche, Lauren H., et al.
Publicado: (2021)

Reply: Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Heo, Sang Taek
Publicado: (2022)

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
por: Lim, Wey Wen, et al.
Publicado: (2021)

mRNA vaccines and clinical research in Africa - From hope to reality
por: Saied, AbdulRahman A.
Publicado: (2022)

Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
por: Uraki, Ryuta, et al.
Publicado: (2023)

Immunogenicity against the Omicron Variant after mRNA-Based COVID-19 Booster Vaccination in Medical Students Who Received Two Primary Doses of the mRNA-1273 Vaccine
por: Chung, Hyemin, et al.
Publicado: (2022)

A left-side channel design improving insertion of gastric tube via the supraglottic airway device
por: Ke, Jing-Dong, et al.
Publicado: (2019)

Papilledema as the Sole Manifestation of Neuroborreliosis
por: May, Kaitlyn, et al.
Publicado: (2021)

Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines
por: Qasim, Hana, et al.
Publicado: (2023)

Reply to Liao et al.: SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis
por: Runnstrom, Martin C., et al.
Publicado: (2022)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Central retinal artery occlusion after Moderna mRNA-1273 vaccination
por: Chow, Sin Yu, et al.
Publicado: (2022)

Severe bullous drug reaction after COVID‐19 mRNA vaccination
por: Irmer, Marie Luise, et al.
Publicado: (2022)

Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia
por: Tadmor, Tamar, et al.
Publicado: (2021)

Thyroid cartilage elevation maneuver: a novel and easy-to-perform method to insert a supraglottic airway device
por: Nah, Sangun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uguffdqcs7f5nbns8c5qilh529